Purchase Order W81K0023P0198
Award Date 10/1/23
Potential Completion Date 9/30/28
Potential Value $3.5M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $1.74M delivery order to Roche Diagnostics Corporation for a fully automated sample preparation and consultation system to support the Department of Pathology and Area Laboratory Services histology laboratory at Brooke Army Medical Center (BAMC) in Fort Sam Houston, Texas. The firm fixed-price contract, which carries no set-aside designation, is scheduled for completion by September 30, 2028, and represents a continuation of Roche's established role as a...
- The Defense Health Agency has exercised the first option period of a firm-fixed-price purchase order with Roche Diagnostics Corporation for reagents, consumables, and controls supporting the COBAS 5800 testing system. The option period runs from October 1, 2025 through September 30, 2026, with a ceiling value of $743,693.30. This contract award follows an initial solicitation issued by Madigan Army Medical Center in March 2024 seeking molecular diagnostics capabilities for Human Papillomavirus...
- The Defense Health Agency awarded a firm fixed-price purchase order to Roche Diagnostics Corporation on October 1, 2020, for viral load testing services at Brooke Army Medical Center, JBSA Fort Sam Houston, Texas. The contract covers molecular diagnostic testing for hepatitis B and C (HBV, HCV), human immunodeficiency virus type 1 (HIV-1), cytomegalovirus (CMV), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and influenza A/B. The contract is valued at $1.88 million with an...
- Roche Diagnostics Corporation has been awarded a $126,006.07 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 10 for human papillomavirus (HPV) testing equipment, supplies, and preventive maintenance services. This is the fourth option year under a Blanket Purchase Agreement established on the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule. The order is scheduled for completion by July 4, 2026, with...
- The Defense Health Agency awarded a Purchase Order to Roche Diagnostics Corporation on October 1, 2024, for maintenance services on a government-owned histological/cytological analyzer at Fort Hood, Texas. This Firm Fixed Price contract, valued at $121,268.59, runs through September 30, 2029, and carries no set-aside designation. The award represents a continuation of DHA's reliance on Roche's diagnostic capabilities to support military medical operations and laboratory functions across the...
- The Department of the Army Medical Command awarded a $147,548.38 delivery order contract to Roche Diagnostics Corporation for the supply of KIT COBAS 4800 HPV AMP/DET 960T. This award was made under Roche's General Services Administration (GSA) Schedule contract for critical laboratory analyzers and equipment. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has a history of providing medical equipment, reagents, and testing services to various federal agencies,...
- This is a delivery order awarded by the Department of the Army Medical Command to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $1,280,000 firm-fixed-price contract is for histology testing services at the Brooke Army Medical Center in JBSA Fort Sam Houston, Texas for Fiscal Year 2020. The contract has no set-aside designation. Roche Diagnostics has a history of providing critical...
- This is a firm-fixed price purchase order awarded to Roche Diagnostics Corporation by the U.S. Army Medical Command (MEDCOM) for the provision of 960 HPV (Human Papillomavirus) detection kits. The contract has a ceiling value of $388,211.32 and a performance period ending on September 30, 2022. The contract was awarded on October 1, 2019 and does not have a set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory...
- Roche Diagnostics Corporation has been awarded a $150.4K firm fixed-price Blanket Purchase Agreement (BPA) call for reagents and consumables to support human papillomavirus (HPV), chlamydia (CT), and neisseria gonorrhoeae (NG) testing. The contract, effective October 1, 2024, with an ultimate completion date of September 30, 2025, was awarded by Veterans Integrated Service Network 12 (a component of the Department of Veterans Affairs) with no set-aside designation. This award is a child contract...
- The Defense Health Agency has awarded a $31,240.66 firm fixed-price contract to Roche Diagnostics Corporation for a laboratory analyzer. This contract, awarded on December 22, 2025, is issued as a call under a Blanket Purchase Agreement (BPA) and is set to complete by September 30, 2026. The work will be performed in Castleton, Indiana. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, specializes in in vitro diagnostic equipment, reagents, and associated...